On May 7, 2025, Y-mAbs announced that naxitamab-gqgk (DANYELZA ®) has been recommended by the National Comprehensive Cancer Network ® ("NCCN”) Clinical Practice Guidelines in Oncology (NCCN Guidelines ...

Planners made a mistake with the size of two major transmission projects, but have an opportunity to get it right for VNI West, and unlock vast areas of onshore wind.